Literature DB >> 15633217

Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method.

Hai-Long Dong1, Yan-Fang Sui.   

Abstract

AIM: To predict the HLA-A2-restricted CTL epitopes of tumor antigens associated with hepatocellular carcinoma (HCC).
METHODS: MAGE-1, MAGE-3, MAGE-8, P53 and AFP were selected as objective antigens in this study for the close association with HCC. The HLA-A*0201 restricted CTL epitopes of objective tumor antigens were predicted by SYFPEITHI prediction method combined with the polynomial quantitative motifs method. The threshold of polynomial scores was set to -24.
RESULTS: The SYFPEITHI prediction values of all possible nonamers of a given protein sequence were added together and the ten high-scoring peptides of each protein were chosen for further analysis in primary prediction. Thirty-five candidates of CTL epitopes (nonamers) derived from the primary prediction results were selected by analyzing with the polynomial method and compared with reported CTL epitopes.
CONCLUSION: The combination of SYFPEITHI prediction method and polynomial method can improve the prediction efficiency and accuracy. These nonamers may be useful in the design of therapeutic peptide vaccine for HCC and as immunotherapeutic strategies against HCC after identified by immunology experiment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633217      PMCID: PMC4205403          DOI: 10.3748/wjg.v11.i2.208

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.

Authors:  Hai-Long Dong; Yan-Fang Sui; Zeng-Shan Li; Ping Qu; Wen Wu; Jing Ye; Xiu-Min Zhang; Shao-Ying Lu
Journal:  Cancer Lett       Date:  2004-08-10       Impact factor: 8.679

Review 3.  New methods to predict MHC-binding sequences within protein antigens.

Authors:  J Hammer
Journal:  Curr Opin Immunol       Date:  1995-04       Impact factor: 7.486

Review 4.  Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Authors:  Kelly A Gebo; Geetanjali Chander; Mollie W Jenckes; Khalil G Ghanem; H Franklin Herlong; Michael S Torbenson; Samer S El-Kamary; Eric B Bass
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells.

Authors:  Andrew Ladhams; Chris Schmidt; Garwin Sing; Lesley Butterworth; George Fielding; Paul Tesar; Russell Strong; Barbara Leggett; Lawrie Powell; Guy Maddern; Kay Ellem; Graham Cooksley
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

6.  A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

Authors:  P van der Bruggen; J Bastin; T Gajewski; P G Coulie; P Boël; C De Smet; C Traversari; A Townsend; T Boon
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

7.  Prediction of peptide affinity to HLA DRB1*0401.

Authors:  K W Marshall; K J Wilson; J Liang; A Woods; D Zaller; J B Rothbard
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

8.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

9.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.

Authors:  J Hammer; E Bono; F Gallazzi; C Belunis; Z Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.